By Jasmine Li
Shares of vaccine-makers fell after reports that Donald Trump is expected to nominate vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Shares of Moderna $(MRNA)$ and Pfizer dropped almost immediately after the initial report by Politico, then rebounded slightly. As of Thursday's market close, Moderna's stock fell 5.6% and Pfizer $(PFE)$ was down 2.6%.
"We're not going to take vaccines away from anybody," Kennedy said in an interview following Trump's victory.
Here's the Wall Street Journal article on Trump's expected appointment of RFK Jr.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
November 14, 2024 16:31 ET (21:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.